General Archive
-
ArticlesAbbVie acquires LifeArc portfolio company DJS Antibodies
AbbVie will pay DJS shareholders approximately $255 million in cash at closing for the acquisition of DJS
-
ArticlesLifeArc’s new fund to advance gene-based medicines for genetic diseases
Researchers can now apply for funding to progress exciting gene therapy research.
-
ArticlesNew toolkit launched to help repurposed medicines reach patients
The toolkit helps researchers, charities and others navigate the opportunities and challenges of repurposing medicines.
-
ArticlesLifeArc scientist awarded prestigious industrial fellowship
LifeArc scientist Finbar Gaffey awarded a coveted industrial fellowship from the Royal Commission for the Exhibition of 1851.
-
ArticlesAisling Burnand CBE, 1964-2022
It is with deep sadness that we share the news that Aisling Burnand CBE passed away on Monday 19 September…
-
ArticlesSeparate science from politics: save the UK’s science sector
LifeArc’s Chief Scientific Officer calls for UK science to continue to be a contributor to the Horizon Europe programme.
-
ArticlesSeven questions about LifeArc’s 2030 ambitions
Melanie Lee talks about LifeArc’s commitment to patients, and explains why we should all care about science translation.
-
ArticlesAdvancing novel gene therapies into the clinic
Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.
-
ArticlesStudy reveals potential new way to treat colorectal cancer
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
-
ArticlesStartup wins first Advise & Connect Innovation Award
iLOF is a startup that has a novel technology with the potential to transform personalised medicine.
-
ArticlesMilner Therapeutics Institute and LifeArc extend strategic partnership
Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics
-
ArticlesAccelerating progress against dementia
How can we reduce the impact of dementia on individuals, families and wider society?